Literature DB >> 14985891

Gene mutation of thiopurine S-methyltransferase in Uygur Chinese.

Jian-Ping Zhang1, Yong-Yuan Guan, An-Long Xu, Shu-Feng Zhou, Jue-Heng Wu, Hong Wei, Min Huang.   

Abstract

OBJECTIVE: This study was to investigate the gene mutation of thiopurine S-methyltransferase (TPMT) in Uygur Chinese.
METHODS: Polymerase chain reaction-based methods were used to analyze three commonly reported inactivating mutations-G238C, G460A and A719G.
RESULTS: One TPMT*3A heterozygote and five TPMT*3C heterozygotes were found in 160 Uygur Chinese subjects, and allele frequencies of TPMT*3A and TPMT*3C were 0.3% and 1.6%, respectively.
CONCLUSION: TPMT*3C is a common mutant allele in Uygur Chinese, while TPMT*3A is a rare mutant allele in Uygur Chinese.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14985891     DOI: 10.1007/s00228-004-0730-7

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  6 in total

1.  The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations.

Authors:  E S Collie-Duguid; S C Pritchard; R H Powrie; J Sludden; D A Collier; T Li; H L McLeod
Journal:  Pharmacogenetics       Date:  1999-02

2.  Ethnic differences in thiopurine methyltransferase pharmacogenetics: evidence for allele specificity in Caucasian and Kenyan individuals.

Authors:  H L McLeod; S C Pritchard; J Githang'a; A Indalo; M M Ameyaw; R H Powrie; L Booth; E S Collie-Duguid
Journal:  Pharmacogenetics       Date:  1999-12

3.  Polymorphism of the thiopurine S-methyltransferase gene in African-Americans.

Authors:  Y Y Hon; M Y Fessing; C H Pui; M V Relling; E Y Krynetski; W E Evans
Journal:  Hum Mol Genet       Date:  1999-02       Impact factor: 6.150

4.  Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance.

Authors:  C R Yates; E Y Krynetski; T Loennechen; M Y Fessing; H L Tai; C H Pui; M V Relling; W E Evans
Journal:  Ann Intern Med       Date:  1997-04-15       Impact factor: 25.391

5.  Thiopurine pharmacogenetics: clinical and molecular studies of thiopurine methyltransferase.

Authors:  R Weinshilboum
Journal:  Drug Metab Dispos       Date:  2001-04       Impact factor: 3.922

Review 6.  Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia.

Authors:  H L McLeod; E Y Krynetski; M V Relling; W E Evans
Journal:  Leukemia       Date:  2000-04       Impact factor: 11.528

  6 in total
  3 in total

1.  Genetic analysis of thiopurine methyltransferase polymorphism in the Jordanian population.

Authors:  Nancy Hakooz; Tawfiq Arafat; Debbie Payne; William Ollier; Sudeep Pushpakom; Julie Andrews; William Newman
Journal:  Eur J Clin Pharmacol       Date:  2010-06-03       Impact factor: 2.953

2.  Distribution of TPMT risk alleles for thiopurine [correction of thioupurine] toxicity in the Israeli population.

Authors:  Edna Efrati; Lior Adler; Norberto Krivoy; Eli Sprecher
Journal:  Eur J Clin Pharmacol       Date:  2008-12-02       Impact factor: 2.953

Review 3.  Clinical pharmacology and pharmacogenetics of thiopurines.

Authors:  Srikumar Sahasranaman; Danny Howard; Sandip Roy
Journal:  Eur J Clin Pharmacol       Date:  2008-05-28       Impact factor: 3.064

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.